Evidence map›Paper›PMID 39938012›Full record

ArticleBlood advances2025

The differential expression of circulating microRNAs in sickle cell trait compared with the normal hemoglobin phenotype.

Kabir Olaniran, Ronak Lakhia, Scott Krinsky, Sagar Nigwekar, Susan Hedayati

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Metabolomic Landscape of Sickle Cell Trait Nephropathy: Illuminating an Under-Recognized Problem.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kabir OlaniranDivision of Nephrology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-1785-960X
Ronak LakhiaDivision of Nephrology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Scott KrinskyDivision of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Sagar NigwekarDivision of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Susan HedayatiDivision of Nephrology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

Funding

UT Southwestern Center for Translational MedicineKL2TR003981 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI ARGENBRIGHT, KEITH EDWARD, TRIVEDI, MADHUKAR H. · 2021 to 2025
$5.9M
Investigating intracellular cholesterol biosynthesis as a regulator of polycystic kidney disease progressionR01DK139033 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Ronak Lakhia · 2025 to 2026
$1.0M
The Role of Peroxisome Proliferator Activated Receptor Alpha in Autosomal Dominant Polycystic Kidney DiseaseK08DK117049 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI LAKHIA, RONAK · 2018 to 2022
$770k
NCATS NIH HHS KL2 TR003981NIDDK NIH HHS K08 DK117049NIDDK NIH HHS R01 DK139033
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39938012
PMCPMC12268627

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.